Abstract: The invention provides an isolated nucleic acid encoding a receptor, other than an immunoglobulin, wherein the receptor binds to a MUC1 tumor antigen independently of an major histocompatibility complex (MHC). The invention provides a method of activating a signaling pathway and/or killing a cancer cell using a receptor that is similar to or is a T cell receptor.
Type:
Grant
Filed:
December 7, 2005
Date of Patent:
February 2, 2010
Assignee:
University of Pittsbugh — Of the Commonwealth System of Higher Education
Inventors:
Olivera J. Finn, Nehad M. Alajez, Jan Schmielau, Mark D. Alter